Dr. Murciano-Goroff is an attending in the Early Drug Development Service at Memorial Sloan Kettering Cancer Center. Her clinical-translational research focuses on phase I/II trials in oncology, with a special emphasis on molecularly targeted therapies. Dr. Murciano-Goroff completed her MD at Harvard University and her DPhil at the University of Oxford. She was a resident at Massachusetts General Hospital, and completed her medical oncology fellowship at Memorial Sloan Kettering Cancer Center.
